Soleno Therapeutics, Inc. (SLNO) Q3 2025 Earnings Name November 4, 2025 4:30 PM EST
Firm Members
Anish Bhatnagar – Chairman, President, CEO & COO
Meredith Manning – Chief Industrial Officer
James MacKaness – CFO & Compliance Officer
Convention Name Members
Brian Ritchie – Lifesci Advisors, LLC
Kyuwon Choi – Goldman Sachs Group, Inc., Analysis Division
Tyler Van Buren – TD Cowen, Analysis Division
Moritz Reiterer – Guggenheim Securities, LLC, Analysis Division
Rick Miller – Cantor Fitzgerald & Co., Analysis Division
Yasmeen Rahimi – Piper Sandler & Co., Analysis Division
Leland Gershell – Oppenheimer & Co. Inc., Analysis Division
Brian Skorney – Robert W. Baird & Co. Integrated, Analysis Division
James Condulis – Stifel, Nicolaus & Firm, Integrated, Analysis Division
Derek Archila – Wells Fargo Securities, LLC, Analysis Division
Yale Jen – Laidlaw & Firm (UK) Ltd., Analysis Division
Katherine Dellorusso
Jade Montgomery
Presentation
Operator
Good afternoon, and thanks for standing by. Welcome to Soleno Therapeutics Third Quarter 2025 Monetary and Working Outcomes Convention Name and webcast. [Operator Instructions]. As a reminder, at the moment’s webcast is being recorded.
I might now prefer to introduce Brian Ritchie of LifeSci Advisors. Please go forward.
Brian Ritchie
Lifesci Advisors, LLC
Thanks. Good afternoon, everybody, and thanks for becoming a member of us to debate Soleno Therapeutics Third Quarter 2025 monetary and working outcomes.
Please word, we might be making sure forward-looking statements at the moment. We refer you to Soleno’s SEC filings for a dialogue of the dangers which will trigger precise outcomes to vary from the forward-looking statements.
On the decision with me at the moment for Soleno are Anish Bhatnagar, Soleno’s Chairman and Chief Government Officer; Meredith Manning, Soleno’s Chief Industrial Officer; and Jim MacKaness, Soleno’s Chief Monetary Officer.
With that, I’ll now flip the decision over to Anish.
Anish Bhatnagar
Chairman, President, CEO & COO
Thanks, Brian, and thanks, everybody, for becoming a member of us for our third quarter outcomes name